Clinical Evaluation of Salivary 1,5-Anhydroglucitol in Diabetes

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The goal of this observational study is to evaluate the clinical value of salivary 1,5-anhydroglucitol (1,5-AG) and assess a novel noninvasive detection approach in individuals with and without type 2 diabetes. Additionally, the study will examine the relationships of salivary 1,5-AG with serum 1,5-AG and continuous glucose monitoring (CGM) measures of short-term glycemic control and fluctuations.
Epistemonikos ID: 8177a9250ee1c962cd03f808437fa89624603ab5
First added on: Aug 26, 2026